Physician profile
John Savidakis
NPI 1750454740
$1,503.30
in general payments reported to CMS, 2019-2025
6 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $590 · 2021: $30.48 · 2023: $442 · 2024: $141 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $654 · Food and Beverage: $67.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $654.00 |
| Food and Beverage | $67.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $654.00 | 2023-2025 | Dr Comfort |
| Smith+Nephew, INC. | $593.17 | 2020-2025 | Collagenase Santyl |
| Wright Medical Technology, INC. | $119.14 | 2019-2020 | |
| Horizon Therapeutics Plc | $99.03 | 2019-2021 | |
| Vertex Pharmaceuticals Incorporated | $32.00 | 2024 | |
| Kerecis Limited | $5.96 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Savidakis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.